THE CONOLIDINE DIARIES

These results, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the concept of targeting ACKR3 as a unique approach to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Problems.Opioid withdrawal can be a agonizing and most